Homology Medicines Inc
Change company Symbol lookup
Select an option...
FIXX Homology Medicines Inc
ASO Academy Sports and Outdoors Inc
PRI Primerica Inc
UAA Under Armour Inc
TGLVY Top Glove Corporation Bhd
ACQRU Independence Holdings Corp
KEGS 1812 Brewing Company Inc
PHUN Phunware Inc
WFC Wells Fargo & Co
XRX Xerox Holdings Corp
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Homology Medicines, Inc. is a clinical-stage genetic medicines company focused on providing treatment for rare genetic diseases. The Company’s clinical programs include HMI-102, is an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria (PKU); HMI-103, which is an investigational gene editing candidate in clinical development for the treatment of patients with PKU, and HMI-203, which is an investigational gene therapy candidate in clinical development for the treatment of patients with mucopolysaccharidosis type II (MPS II), or Hunter syndrome. Additionally, the Company is developing a gene therapy candidate, HMI-104, from its GTx-mAb platform for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH), and conducting research in other diseases, including metachromatic leukodystrophy (MLD). Its platform is designed to utilize human hematopoietic stem cell derived adeno-associated virus vectors.

Price
Delayed
$1.49
Day's Change
-0.0142 (-0.95%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.54
Day's Low
1.46
Volume
(Light)

Today's volume of 69,826 shares is on pace to be much lighter than FIXX's 10-day average volume of 207,247 shares.

69,826
  • Prev Close
    1.50
  • Today's Open
    1.50
  • Day's Range
    1.46-1.54
  • Avg Vol (10-day)
    207.2K
  • Last (time)
    1:54p ET 12/02/22
  • Last (size)
    100
  • 52-Wk Range
    1.30 - 5.15
    LowHigh
  • (12/09/21 - 11/09/22)
    14.29%
  • 103.7%
  • Market Cap
    85.4M
  • Shares Outstanding
    57.5M
  • -0.09
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -0.2
  • 49.92
  • (% of float 11/15/22)
    2.04

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.